All Biotech News

List of articles in category All Biotech News
Title	Published Date
Mucosis Initiates First-in-Human Study of SynGEM®, a Needle-Free Nasal Spray RSV Vaccine	11/07/2016
Atriva Therapeutics Announces Upcoming US Patent Issuance for MEK Treatment against Viral Diseases	11/04/2016
ARTES and BioSun Announce Co-Development for HPV Vaccine	11/04/2016
RedHill Biopharma Provides Update on Ongoing Phase III and Phase II Studies with BEKINDA® and Expected Timing of Top-Line Results	11/03/2016
NBE Therapeutics Raises CHF 20 Million in Series B Funding	11/03/2016
RedHill Biopharma Announces Proposed Public Offering of its American Depository Shares	11/02/2016
Agendia Announces the Award of a New Category 1 CPT Code from the American Medical Association for the MammaPrint® 70-Gene Breast Cancer Recurrence Assay	11/01/2016
Atomo Diagnostics Receives Grant to Develop New, Innovative HIV Self-Test Solution	10/27/2016
Agendia Expands its Business Activities in Germany	10/26/2016
BioPharmaSpec Appoints Two Senior Technical Staff from the CRO and Biosimilar Fields	10/25/2016
SOTIO and NBE Therapeutics Sign Collaboration and License Agreement for Next-Generation Antibody-Drug Conjugates	10/20/2016
Synaffix Enters into a Commercial License Agreement with ADC Therapeutics	10/20/2016
RedHill Biopharma Announces Allowance of a Patent in Japan Supporting RHB-104 for Multiple Sclerosis	10/18/2016
Agendia Appoints Three Leading Cancer Physicians to Its Medical Advisory Board	10/17/2016
Hookipa Secures ‎EUR 4.16 Million Additional Grant Support from the Austrian Research Promotion Agency (FFG) to Develop Arenavirus Vector-Based Cancer Immunotherapies	10/17/2016
RedHill Biopharma to Host Webcast Today at 8:30 am EDT Following Announcement of Progress Update on RHB-104 Phase III Crohn’s Disease Program	10/06/2016
RedHill Biopharma Provides Progress Update on RHB-104 Phase III Crohn’s Disease Program and Introduces Option for Early Stop for Success in Q2/2017	10/06/2016
Orchard Therapeutics Announces the Opening of US Operations in Foster City, California	10/06/2016
RedHill Biopharma Announces Initiation of Phase II Study with YELIVA™ in Hepatocellular Carcinoma at the Medical University of South Carolina	10/05/2016
Vector Vitale Announces New Paradigm in Medicine	10/05/2016
Karus Therapeutics Announces First Lymphoma Patients Dosed with KA2237 in Clinical Study at the MD Anderson Cancer Center	10/05/2016
Nuevolution Announces Strategic Collaboration with Amgen in Oncology and Neuroscience	10/04/2016
Argint International Voted as Top10 CRO	10/04/2016
Sartorius Stedim Biotech Launches Two Single-Use Sartocon® Loop Assemblies with Integrated Polyethersulfone (PESU) Membrane	09/30/2016
Dutch Mellon Medical Unveils Major Innovation in Surgical Suture Technology: Single-Handed Suturing Using The Switch®	09/30/2016
Quantapore Inc. Closes Series C Financing Round	09/27/2016
Shuwen Biotech's Clinical Lab Receives Accreditation from College of American Pathologists	09/23/2016
Nuevolution: Oral Presentation of Preclinical and Preliminary Toxicology Data on its BET BD1 Program at Discovery on Target 2016	09/22/2016
Orchard Therapeutics Announces Presentations from UCL/GOSH and UCLA Academic Collaborators on Clinical Data in ADA-SCID Using Ex-Vivo Lentiviral Gene Therapy at September 2016 ESID and ESGCT Congresses	09/21/2016
FierceBiotech Names Orchard Therapeutics Limited as One of Its “Fierce 15” Biotech Companies of 2016	09/21/2016

Page 45 of 88